Katsuhiro Yoshikawa

728 total citations
28 papers, 357 citations indexed

About

Katsuhiro Yoshikawa is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Katsuhiro Yoshikawa has authored 28 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Katsuhiro Yoshikawa's work include Cancer Cells and Metastasis (6 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Katsuhiro Yoshikawa is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Katsuhiro Yoshikawa collaborates with scholars based in Japan. Katsuhiro Yoshikawa's co-authors include Mizuo Miyazaki, Hirotsugu Yanai, Koji Tsuta, Mitsuaki Ishida, Tomoharu Sugie, Mitsugu Sekimoto, Denan Jin, Shinji Takai, Yoshiki Mino and Michiko Muramatsu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Katsuhiro Yoshikawa

26 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katsuhiro Yoshikawa Japan 11 114 105 101 96 48 28 357
Leilani E. Beltran United Kingdom 6 60 0.5× 104 1.0× 205 2.0× 41 0.4× 41 0.9× 6 454
Beatriz Herránz Spain 8 52 0.5× 83 0.8× 97 1.0× 60 0.6× 61 1.3× 8 384
Karoline Fechter Austria 8 74 0.6× 93 0.9× 115 1.1× 48 0.5× 55 1.1× 12 301
Rute Moura Belgium 5 57 0.5× 90 0.9× 157 1.6× 39 0.4× 76 1.6× 8 352
Elena Ninci Germany 9 87 0.8× 104 1.0× 107 1.1× 75 0.8× 34 0.7× 10 324
K. Fukino Japan 6 72 0.6× 61 0.6× 207 2.0× 62 0.6× 79 1.6× 13 388
Yaw Asare Germany 13 88 0.8× 299 2.8× 189 1.9× 65 0.7× 61 1.3× 23 563
Elena Nefyodova Belgium 8 53 0.5× 49 0.5× 150 1.5× 64 0.7× 62 1.3× 11 371
Edith Renaud-Gabardos France 11 120 1.1× 52 0.5× 224 2.2× 66 0.7× 102 2.1× 12 416
Naohiro Ohashi Japan 7 81 0.7× 116 1.1× 178 1.8× 100 1.0× 48 1.0× 9 433

Countries citing papers authored by Katsuhiro Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Katsuhiro Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhiro Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhiro Yoshikawa more than expected).

Fields of papers citing papers by Katsuhiro Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuhiro Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhiro Yoshikawa. The network helps show where Katsuhiro Yoshikawa may publish in the future.

Co-authorship network of co-authors of Katsuhiro Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuhiro Yoshikawa. A scholar is included among the top collaborators of Katsuhiro Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuhiro Yoshikawa. Katsuhiro Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, et al.. (2022). Prognostic significance of the expression levels of T‑cell immunoglobulin mucin‑3 and its ligand galectin‑9 for relapse‑free survival in triple‑negative breast cancer. Oncology Letters. 23(6). 197–197. 7 indexed citations
2.
Yoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, et al.. (2021). Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer. BMC Cancer. 21(1). 239–239. 31 indexed citations
3.
Yoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, et al.. (2021). Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients. PLoS ONE. 16(6). e0253176–e0253176. 14 indexed citations
4.
Yoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, et al.. (2021). Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer. PLoS ONE. 16(9). e0257860–e0257860. 3 indexed citations
5.
Yanai, Hirotsugu, Katsuhiro Yoshikawa, Mitsuaki Ishida, et al.. (2021). Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study. PLoS ONE. 16(2). e0245725–e0245725. 15 indexed citations
6.
Yoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, et al.. (2020). Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study. PLoS ONE. 15(11). e0242563–e0242563. 15 indexed citations
7.
Yoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, et al.. (2020). Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy. World Journal of Surgical Oncology. 18(1). 177–177. 8 indexed citations
8.
Yamamoto, Daigo, et al.. (2019). [Abnormal Nipple Discharge].. PubMed. 46(2). 378–379. 2 indexed citations
9.
Yoshikawa, Katsuhiro, et al.. (2018). [Radiotherapy and Eribulin Mesylate for Mediastinal Node Metastasis from Breast Cancer-A Case Report].. PubMed. 45(13). 2177–2179. 1 indexed citations
10.
Yamawaki, Satoko, Motoko Naitoh, Hiroshi Kubota, et al.. (2018). HtrA1 Is Specifically Up-Regulated in Active Keloid Lesions and Stimulates Keloid Development. International Journal of Molecular Sciences. 19(5). 1275–1275. 8 indexed citations
11.
Kawashima, Masahiro, Kosuke Kawaguchi, Megumi Takeuchi, et al.. (2018). Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels. International Cancer Conference Journal. 7(3). 107–113. 15 indexed citations
12.
Yamamoto, Daigo, et al.. (2018). [A Successful Treatment of Locally Advanced Breast Cancer with Using Mohs' Paste and Chemotherapy - A Case Report].. PubMed. 45(4). 725–727. 1 indexed citations
13.
Yamamoto, Daigo, et al.. (2016). Osteonecrosis of the jaw associated with everolimus: A case report. Molecular and Clinical Oncology. 6(2). 255–257. 25 indexed citations
14.
Yamamoto, Daigo, et al.. (2016). [Effectiveness of Postoperative Physical Therapy for Upper-Limb Impairments after Breast Cancer Treatment].. PubMed. 43(12). 1458–1460. 1 indexed citations
15.
Yoshikawa, Katsuhiro, Motoko Naitoh, Hiroshi Kubota, et al.. (2012). Multipotent stem cells are effectively collected from adult human cheek skin. Biochemical and Biophysical Research Communications. 431(1). 104–110. 9 indexed citations
16.
Takai, Shinji, Daisuke Yamamoto, Denan Jin, et al.. (2007). Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters. European Journal of Pharmacology. 568(1-3). 231–233. 21 indexed citations
17.
Kanemitsu, Hideo, Shinji Takai, Hiroshi Tsuneyoshi, et al.. (2006). Chymase Inhibition Prevents Cardiac Fibrosis and Dysfunction after Myocardial Infarction in Rats. Hypertension Research. 29(1). 57–64. 61 indexed citations
18.
Takai, Shinji, Denan Jin, Michiko Muramatsu, et al.. (2005). Significance of Angiotensin II Receptor Blocker Lipophilicities and Their Protective Effect against Vascular Remodeling. Hypertension Research. 28(7). 593–600. 55 indexed citations
19.
Takai, Shinji, Denan Jin, Michiko Muramatsu, et al.. (2005). Role of Chymase-Dependent Angiotensin II Formation in Regulating Blood Pressure in Spontaneously Hypertensive Rats. Hypertension Research. 28(5). 457–464. 37 indexed citations
20.
Sakai, T, et al.. (1993). [A case report of cardiac failure caused by the new anti-neoplastic agent 'carboplatin'].. PubMed. 42(5). 756–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leilani E. Beltran Breakdown of academic impact, for papers by Beatriz Herránz Breakdown of academic impact, for papers by Karoline Fechter Breakdown of academic impact, for papers by Rute Moura Breakdown of academic impact, for papers by Elena Ninci Breakdown of academic impact, for papers by K. Fukino Breakdown of academic impact, for papers by Yaw Asare Breakdown of academic impact, for papers by Elena Nefyodova Breakdown of academic impact, for papers by Edith Renaud-Gabardos Breakdown of academic impact, for papers by Naohiro Ohashi
Rankless by CCL
2026